Li L - Search Results

1

Neuroprotective role of (Val(8))GLP-1-Glu-PAL in an in vitro model of Parkinson's disease.

Li L, Liu K, Zhao J, Holscher C, Li GL, Liu YZ. Li L, et al. Among authors: li gl. Neural Regen Res. 2016 Feb;11(2):326-31. doi: 10.4103/1673-5374.177742. Neural Regen Res. 2016. PMID: 27073388 Free PMC article.

2

Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model.

Zhang Y, Chen Y, Li L, Hölscher C. Zhang Y, et al. Among authors: li l. Behav Brain Res. 2015 Oct 15;293:107-13. doi: 10.1016/j.bbr.2015.07.021. Epub 2015 Jul 14. Behav Brain Res. 2015. PMID: 26187689

3

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.

Ji C, Xue GF, Lijun C, Feng P, Li D, Li L, Li G, Hölscher C. Ji C, et al. Among authors: li d, li g, li l. Brain Res. 2016 Mar 1;1634:1-11. doi: 10.1016/j.brainres.2015.09.035. Epub 2015 Oct 11. Brain Res. 2016. PMID: 26453833 Free article.

4

Geniposide prevents rotenone-induced apoptosis in primary cultured neurons.

Li L, Zhao J, Liu K, Li GL, Han YQ, Liu YZ. Li L, et al. Among authors: li gl. Neural Regen Res. 2015 Oct;10(10):1617-21. doi: 10.4103/1673-5374.167760. Neural Regen Res. 2015. PMID: 26692859 Free PMC article.

5

D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.

Li Y, Liu W, Li L, Hölscher C. Li Y, et al. Among authors: li l. Eur J Pharmacol. 2017 Feb 15;797:162-172. doi: 10.1016/j.ejphar.2016.11.050. Epub 2016 Nov 29. Eur J Pharmacol. 2017. PMID: 27913104 Free article.

6

Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide dual receptor agonist DA-CH5 is superior to exendin-4 in protecting neurons in the 6-hydroxydopamine rat Parkinson model.

Zhang LY, Jin QQ, Hölscher C, Li L. Zhang LY, et al. Among authors: li l. Neural Regen Res. 2021 Aug;16(8):1660-1670. doi: 10.4103/1673-5374.303045. Neural Regen Res. 2021. PMID: 33433498 Free PMC article.

7

A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain.

Cao L, Li D, Feng P, Li L, Xue GF, Li G, Hölscher C. Cao L, et al. Among authors: li d, li g, li l. Neuroreport. 2016 Apr 13;27(6):384-91. doi: 10.1097/WNR.0000000000000548. Neuroreport. 2016. PMID: 26918675

8

(Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.

Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ. Li L, et al. Eur J Pharmacol. 2012 Jan 15;674(2-3):280-6. doi: 10.1016/j.ejphar.2011.11.005. Epub 2011 Nov 12. Eur J Pharmacol. 2012. PMID: 22115895

9

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease.

Gao C, Hölscher C, Liu Y, Li L. Gao C, et al. Among authors: li l. Rev Neurosci. 2011 Dec 21;23(1):1-11. doi: 10.1515/rns.2011.061. Rev Neurosci. 2011. PMID: 22718609 Review.

10

Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease.

Liu W, Li Y, Jalewa J, Saunders-Wood T, Li L, Hölscher C. Liu W, et al. Among authors: li y, li l. Eur J Pharmacol. 2015 Oct 15;765:284-90. doi: 10.1016/j.ejphar.2015.08.038. Epub 2015 Aug 21. Eur J Pharmacol. 2015. PMID: 26302060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,394 results

Search Page

Filters